NFKB1 and lung cancer: To further address the contribution of IKK to oncogenic RAS-driven NF-κB activity, human as well as mouse lung cancer cell lines harboring oncogenic KRAS were transfected with an NF-κB-dependent luciferase reporter and treated with CmpdA.